Searchable abstracts of presentations at key conferences in endocrinology

ea0089p7 | Population Science | NANETS2022

Feasibility of e-NET: A Web-Based Health Platform to Investigate Quality of Life in Patients with Neuroendocrine Tumors

Mulvey Claire K. , Steiding Paige , Moon Farhana , Paciorek Alan , Zhang Li , Bergsland Emily K.

Background: Patients with neuroendocrine neoplasms (NENs) have chronic symptoms from hormone overproduction, tumor growth and metastasis, and side effects from prolonged treatment. We assessed the feasibility of using a digital health platform to recruit patients with NENs to evaluate symptoms and quality of life.Methods: eNET is a prospective, web-based, cohort study for patients with advanced NENs of any primary site, histologic grade, differentiation,...

ea0098p10 | Population Science | NANETS2023

Quality of life differs by age and sex for participants with advanced neuroendocrine neoplasms in the eNET study

Mulvey Claire K. , Paciorek Alan , Steiding Paige , Moon Farhana , Zhang Li , Bergsland Emily K.

Background: Patients with neuroendocrine neoplasms (NENs) have a high burden of chronic symptoms. We assessed symptom burden and overall quality of life (QOL) for eNET study participants and analyzed differences by age, sex, and NEN primary site.Methods: eNET is a prospective, cohort study on the Eureka digital health platform enrolling individuals with advanced NENs. Participants completed validated surveys on an internet-supported device at baseline an...

ea0098c16 | Clinical – Chemo/SSA/Biologics | NANETS2023

Comparison of well-differentiated gastroenteropancreatic grade 3 neuroendocrine tumors (G3NETS): de novo and in the setting of apparent grade progression over time

Khuong Le Bryan , Paciorek Alan , Moon Farhana , Lawhn Heath Courtney , Hope Thomas , Fidelman Nicholas , Mulvey Claire , Lindsay Sheila , Zhang¬ Li , Nakakura Eric , Joseph Nancy , Bergsland Emily K.

Background: G3NETs demonstrate variable clinical behavior (Ki-67>20-100%). Treatment extrapolated from grade 1/2 (G1/2) NETs and neuroendocrine carcinomas depending on clinicopathologic features. Therapy for treatment-emergent G3NETs remains especially ill-defined.Methods: Retrospective chart review of patients with de novo G3NETs or progressing from low-to-high grade (L-H) (G1/2 at diagnosis and G3 >=3 months later). Treatment patterns compared ...

ea0098p5 | Population Science | NANETS2023

Higher serotonin levels from ileum neuroendocrine tumors are associated with mesenteric mass progression

Yogo Akitada , Paciorek Alan , Moon Farhan , Bergsland Emily K. , Alseidi Adnan , Adam Mohamed , Maker Ajay , Corvera Carlos , Hirose Kenzo , Nakakura Eric K.

Background: Serotonin produced by ileum neuroendocrine tumors (i-NETs) promotes development of the mesenteric mass (MM) associated with lymph node metastases. We previously reported that more extensive MM progression along the superior mesenteric vessels predicts a lower rate of complete surgical resection. In this study, we hypothesized that tumoral serotonin production is associated not only with the development of MM but also its progression, and we examined serotonin level...

ea0098p6 | Population Science | NANETS2023

The use of antidepressants is associated with mesenteric mass formation of ileum neuroendocrine tumors

Yogo Akitada , Paciorek Alan , Moon Farhan , Bergsland Emily K. , Alseidi Adnan , Adam Mohamed , Maker Ajay , Corvera Carlos , Hirose Kenzo , Nakakura Eric K.

Background: Serotonin production by ileum neuroendocrine tumors (i-NETs) is considered a critical mediator of the fibrotic reaction in mesenteric mass (MM)/ lymph node metastasis. Antidepressants modify serotonin dynamics: however, their role in MM formation is uncertain. We hypothesized that histories of antidepressant use affect MM formation. This study examined the correlation between antidepressant use and MM formation.Methods: One hundred eighty-two...